Crescita acquired by ClinActiv in all-cash transaction

Goodmans LLP advised Crescita Therapeutics Inc. in connection with its acquisition by ClinActiv Holdings Inc. and its affiliate in an all-cash transaction that implied an equity value for Crescita of approximately C$15 million and consideration of C$0.80 per share.

The transaction provided Crescita’s shareholders with immediate liquidity at a significant premium to the trading price of the shares prior to the transaction’s announcement.

Crescita is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities.

ClinActiv is a global dermatology and consumer health platform focused on building science-driven products and businesses through cross-border collaboration, strategic partnerships and targeted acquisitions.